BiotechTube
Home/Viracta Therapeutics/Darrel P. Cohen
DP

Darrel P. Cohen

Former Chief Medical Officer

Viracta Therapeutics

Therapeutic Areas

OncologyInfectious Disease (Virus-associated)

Viracta Therapeutics Pipeline

DrugIndicationPhase
Nanatinostat + Valganciclovir (Nana-val)Relapsed/Refractory EBV+ Lymphomas (PTCL, CTCL, DLBCL)Phase 2

Leadership Team at Viracta Therapeutics

IR
Ivor Royston
Former CEO, President, and Co-Founder
MR
Mark Rothera
Former President and CEO
DR
Daniel R. Chevallard
Former COO and CFO
JK
John K. H. North
Former Chairman of the Board
View full Viracta Therapeutics profile